淋巴增生性疾病的临床试验
总计143109个结果
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
European Organisation for Research and Treatment...完全的
-
Hospices Civils de Lyon未知
-
University of NebraskaNational Cancer Institute (NCI)完全的
-
Toronto Sunnybrook Regional Cancer Centre未知
-
M.D. Anderson Cancer CenterSpectrum Pharmaceuticals, Inc完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong终止
-
Centre Hospitalier Universitaire, Amiens未知
-
University of Michigan Rogel Cancer CenterGlaxoSmithKline; Gilead Sciences撤销
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ortho Biotech, Inc.完全的
-
WiSP Wissenschaftlicher Service Pharma GmbHLudwig-Maximilians - University of Munich; Chugai Pharma GmbH完全的霍奇金病 | 非霍奇金淋巴瘤 | 多发性骨髓瘤
-
Beijing Doing Biomedical Co., Ltd.The First Hospital of Jilin University; Hebei Yanda Ludaopei Hospital尚未招聘
-
Shin MineishiMilton S. Hershey Medical Center撤销
-
Hoffmann-La Roche完全的
-
Progen Pharmaceuticals完全的
-
Jonsson Comprehensive Cancer CenterAmgen完全的淋巴瘤 | 白血病 | 贫血 | 未明确的成人实体瘤,特定方案 | 多发性骨髓瘤和浆细胞肿瘤 | 淋巴增生性疾病 | 癌前/非恶性疾病美国
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Virginia Commonwealth UniversityAmerican Heart Association; National Center for Advancing Translational Sciences (NCATS)招聘中
-
University of East AngliaClinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)未知
-
University of Michigan Rogel Cancer CenterAmerican Institute for Cancer Research招聘中